Paul Alloway's most recent trade in Q32 Bio Inc. was a trade of 7,280 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Jan. 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Q32 Bio Inc. | Paul Alloway | See Remarks | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 03 Jan 2024 | 7,280 | 28,036 (0%) | 0% | 0.6 | 4,120 | Common Stock |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 8,910 | 18,090 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Alloway Paul | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 8,910 | 35,316 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 5,280 | 26,406 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 5,280 | 5,440 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 4,420 | 0 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Alloway Paul | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 4,420 | 21,126 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Sale of securities on an exchange or to another person at price $ 1.45 per share. | 02 Mar 2023 | 10,965 | 16,706 (0%) | 0% | 1.4 | 15,863 | Common Stock |
Q32 Bio Inc. | Paul Alloway | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 164,000 | 164,000 | - | - | Employee Stock Option (Right to Buy) | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,000 | 27,000 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 5,280 | 23,193 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 5,280 | 10,720 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 4,290 | 4,420 | - | - | Restricted Stock Units | |
Q32 Bio Inc. | Paul Alloway | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 4,290 | 17,913 (0%) | 0% | - | Common Stock |